Skip to main content
. 2022 May 15;14(5):1059. doi: 10.3390/pharmaceutics14051059

Figure 4.

Figure 4

ATR-FTIR spectra of (A) NG, HPβCD, NG + HPβCD physical mixture (PM), and NG/HPβCD complex and (B) NG, CDI-HPβNS, NG + CDI-HPβNS physical mixture (PM), and NG/CDI-HPβNS.